drugset / Trial / NCT07608562

Azithromycin for Cerclage Prophylaxis

NCT07608562

Phase 4 Not yet recruiting 80 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.

Timeline

Start
2026-08
Primary completion
2028-06
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg Intravenous
Background Cefazolin Small molecule 2 g
Background Cefazolin Small molecule 3 g

Indications